These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17548941)

  • 1. Low dose radiation increased the therapeutic efficacy of cyclophosphamide on S(180) sarcoma bearing mice.
    Yu HS; Xue HW; Guo CB; Song AQ; Shen FZ; Liang J; Deng C
    J Radiat Res; 2007 Jul; 48(4):281-8. PubMed ID: 17548941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of low dose pre-irradiation on hepatic damage and genetic material damage caused by cyclophosphamide.
    Yu HS; Song AQ; Liu N; Wang H
    Eur Rev Med Pharmacol Sci; 2014; 18(24):3889-97. PubMed ID: 25555880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repair capacity of mouse lung after total body irradiation alone or combined with cyclophosphamide.
    Safwat A; Bentzen SM; Nielsen OS; Mahmoud HK; Overgaard J
    Radiother Oncol; 1996 Sep; 40(3):249-57. PubMed ID: 8940753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of radiation dose rate and cyclophosphamide on pulmonary toxicity after total body irradiation in a mouse model.
    Safwat A; Nielsen OS; El-Badawy S; Overgaard J
    Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):85-91. PubMed ID: 12118569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.
    Proietti E; Greco G; Garrone B; Baccarini S; Mauri C; Venditti M; Carlei D; Belardelli F
    J Clin Invest; 1998 Jan; 101(2):429-41. PubMed ID: 9435316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose radiation (LDR) induces hematopoietic hormesis: LDR-induced mobilization of hematopoietic progenitor cells into peripheral blood circulation.
    Li W; Wang G; Cui J; Xue L; Cai L
    Exp Hematol; 2004 Nov; 32(11):1088-96. PubMed ID: 15539087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth-inhibition of S180 residual-tumor by combination of cyclophosphamide and chitosan oligosaccharides in vivo.
    Zhai X; Yuan S; Yang X; Zou P; Shao Y; Abd El-Aty AM; Hacımüftüoğlu A; Wang J
    Life Sci; 2018 Jun; 202():21-27. PubMed ID: 29626528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of etanidazole with cyclophosphamide and platinum complexes.
    Teicher BA; Herman TS; Shulman L; Bubley G; Coleman CN; Frei E
    Cancer Chemother Pharmacol; 1991; 28(3):153-8. PubMed ID: 1830248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ganoderma atrum polysaccharide induces anti-tumor activity via the mitochondrial apoptotic pathway related to activation of host immune response.
    Li WJ; Chen Y; Nie SP; Xie MY; He M; Zhang SS; Zhu KX
    J Cell Biochem; 2011 Mar; 112(3):860-71. PubMed ID: 21328459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclophosphamide as a potent inhibitor of tumor thioredoxin reductase in vivo.
    Wang X; Zhang J; Xu T
    Toxicol Appl Pharmacol; 2007 Jan; 218(1):88-95. PubMed ID: 17156807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of triterpenoid fractions from the rhizomes of Astilbe chinensis on cyclophosphamide-induced toxicity in tumor-bearing mice.
    Sun HX; Peng XY
    J Ethnopharmacol; 2008 Sep; 119(2):312-7. PubMed ID: 18692125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soy-Based Multiple Amino Acid Oral Supplementation Increases the Anti-Sarcoma Effect of Cyclophosphamide.
    Yao CA; Chen CC; Wang NP; Chien CT
    Nutrients; 2016 Apr; 8(4):192. PubMed ID: 27043621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Synergism and attenuation effects of taurine on cyclophosphamide].
    Zhao N; Wang L; Mou HY; Liang M; Yue W
    Ai Zheng; 2009 Mar; 28(3):244-8. PubMed ID: 19619437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of WR-2721 and cyclophosphamide on the cell cycle phase specificity of apoptosis in mouse bone marrow.
    Mazur L; Augustynek A; Deptała A; Halicka HD; Bedner E
    Anticancer Drugs; 2002 Aug; 13(7):751-8. PubMed ID: 12187332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Shenfu injection on immune function of mice bearing Lewis lung sarcoma with chemotherapy.
    Luo Y; Wang K; Li Q; Lang J
    Tumour Biol; 2016 Aug; 37(8):10187-91. PubMed ID: 26831661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of icaritin on hematopoietic function in cyclophosphamide-induced myelosuppression mice.
    Sun C; Yang J; Pan L; Guo N; Li B; Yao J; Wang M; Qi C; Zhang G; Liu Z
    Immunopharmacol Immunotoxicol; 2018 Feb; 40(1):25-34. PubMed ID: 29077519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta in in vivo resistance.
    Teicher BA; Holden SA; Ara G; Chen G
    Cancer Chemother Pharmacol; 1996; 37(6):601-9. PubMed ID: 8612316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of interferon regulatory factor 1 in governing Treg depletion, Th1 polarization, inflammasome activation and antitumor efficacy of cyclophosphamide.
    Buccione C; Fragale A; Polverino F; Ziccheddu G; Aricò E; Belardelli F; Proietti E; Battistini A; Moschella F
    Int J Cancer; 2018 Mar; 142(5):976-987. PubMed ID: 28975621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulated heme oxygenase-1 expression of mouse mesenchymal stem cells resists to chemotherapy-induced bone marrow suppression.
    Chen S; Wang J; Fang Q; Gao R; Shi Q; Zhang H; Zhao J
    Chin Med J (Engl); 2014; 127(7):1310-6. PubMed ID: 24709186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of scheduling on two-drug combinations of alkylating agents in vivo.
    Teicher BA; Holden SA; Jones SM; Eder JP; Herman TS
    Cancer Chemother Pharmacol; 1989; 25(3):161-6. PubMed ID: 2513139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.